Low dose entecavir formulation and use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/522 (2006.01) A61K 9/20 (2006.01) A61P 31/20 (2006.01) A61K 9/48 (2006.01)

Patent

CA 2401569

Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose of entecavir are provided. Other pharmaceutically active substances can be included in the entecavir composition or can be separately administered for the treatment of hepatitis B virus infection or for the treatment of co-infected patients.

L'invention concerne des compositions contenant une faible dose d'entecavir, administrées quotidiennement dans le traitement de l'infection par le virus de l'hépatite B et/ou des co-infections. L'invention porte sur des formulations destinées à l'administration par voie orale d'une faible dose d'entecavir. D'autres substances actives d'un point de vue pharmacologique peuvent être incluses dans la composition d'entecavir ou administrées séparément pour traiter l'infection par le virus de l'hépatite B ou pour le traitement de patients co-infectés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Low dose entecavir formulation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Low dose entecavir formulation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low dose entecavir formulation and use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1581346

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.